Updates in the Management of Demodex Blepharitis

home / k-cast / updates-in-the-management-of-demodex-blepharitis

Douglas K Devries, OD, discusses an overview on treatment pathways and burden of disease associated with Demodex blepharitis.

Prevalence and Incidence of Demodex Blepharitis

EP. 1: Prevalence and Incidence of Demodex Blepharitis

November 1st 2022

Douglas K Devries, OD, illustrates the current prevalence of patients diagnosed with Demodex blepharitis.

Watch

Risk Factors for Developing Demodex Blepharitis

EP. 2: Risk Factors for Developing Demodex Blepharitis

November 8th 2022

Douglas K. Devries, OD, outlines the common risk factors associated with Demodex blepharitis.

Watch

Economic Burden and Quality of Life Impact Associated with Demodex Blepharitis

EP. 3: Economic Burden and Quality of Life Impact Associated with Demodex Blepharitis

November 15th 2022

Douglas K. Devries, OD, discusses how Demodex blepharitis affects patients’ quality of life and associated financial burden.

Watch

Lack of Guidelines Impacting Demodex Blepharitis Treatment Landscape

EP. 4: Lack of Guidelines Impacting Demodex Blepharitis Treatment Landscape

November 22nd 2022

A lack of guidelines impair the management of Demodex blepharitis.

Watch

Trajectory of Demodex Blepharitis Treatment Pathways

EP. 5: Trajectory of Demodex Blepharitis Treatment Pathways

November 29th 2022

Douglas K. Devries, OD, shares his final insights, highlighting prospective emerging treatments for Demodex blepharitis.

Watch

© 2025 MJH Life Sciences

All rights reserved.